These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10864639)

  • 1. Isolation and characterization of monoclonal antibodies that inhibit hepatitis C virus NS3 protease.
    Ueno T; Misawa S; Ohba Y; Matsumoto M; Mizunuma M; Kasai N; Tsumoto K; Kumagai I; Hayashi H
    J Virol; 2000 Jul; 74(14):6300-8. PubMed ID: 10864639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of hepatitis C virus NS3 protease by peptides derived from complementarity-determining regions (CDRs) of the monoclonal antibody 8D4: tolerance of a CDR peptide to conformational changes of a target.
    Tsumoto K; Misawa S; Ohba Y; Ueno T; Hayashi H; Kasai N; Watanabe H; Asano R; Kumagai I
    FEBS Lett; 2002 Aug; 525(1-3):77-82. PubMed ID: 12163165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanistic role of an NS4A peptide cofactor with the truncated NS3 protease of hepatitis C virus: elucidation of the NS4A stimulatory effect via kinetic analysis and inhibitor mapping.
    Landro JA; Raybuck SA; Luong YP; O'Malley ET; Harbeson SL; Morgenstern KA; Rao G; Livingston DJ
    Biochemistry; 1997 Aug; 36(31):9340-8. PubMed ID: 9235976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the hepatitis C virus NS3 protease activity by Fv fragment of antibody 8D4.
    Kasai N; Tsumoto K; Niwa S; Misawa S; Ueno T; Hayashi H; Kumagai I
    Biochem Biophys Res Commun; 2001 Feb; 281(2):416-24. PubMed ID: 11181064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of hepatitis C virus NS3 proteinase activity by association with NS4A-specific synthetic peptides: identification of sequence and critical residues of NS4A for the cofactor activity.
    Butkiewicz NJ; Wendel M; Zhang R; Jubin R; Pichardo J; Smith EB; Hart AM; Ingram R; Durkin J; Mui PW; Murray MG; Ramanathan L; Dasmahapatra B
    Virology; 1996 Nov; 225(2):328-38. PubMed ID: 8918919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virus-specific cofactor requirement and chimeric hepatitis C virus/GB virus B nonstructural protein 3.
    Butkiewicz N; Yao N; Zhong W; Wright-Minogue J; Ingravallo P; Zhang R; Durkin J; Standring DN; Baroudy BM; Sangar DV; Lemon SM; Lau JY; Hong Z
    J Virol; 2000 May; 74(9):4291-301. PubMed ID: 10756044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serine protease of hepatitis C virus expressed in insect cells as the NS3/4A complex.
    Sali DL; Ingram R; Wendel M; Gupta D; McNemar C; Tsarbopoulos A; Chen JW; Hong Z; Chase R; Risano C; Zhang R; Yao N; Kwong AD; Ramanathan L; Le HV; Weber PC
    Biochemistry; 1998 Mar; 37(10):3392-401. PubMed ID: 9521660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The hepatitis C virus NS3 serine proteinase and NS4A cofactor: establishment of a cell-free trans-processing assay.
    Lin C; Rice CM
    Proc Natl Acad Sci U S A; 1995 Aug; 92(17):7622-6. PubMed ID: 7644466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A central hydrophobic domain of the hepatitis C virus NS4A protein is necessary and sufficient for the activation of the NS3 protease.
    Tomei L; Failla C; Vitale RL; Bianchi E; De Francesco R
    J Gen Virol; 1996 May; 77 ( Pt 5)():1065-70. PubMed ID: 8609472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzymatic characterization of membrane-associated hepatitis C virus NS3-4A heterocomplex serine protease activity expressed in human cells.
    Hamill P; Jean F
    Biochemistry; 2005 May; 44(17):6586-96. PubMed ID: 15850392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineering, characterization and phage display of hepatitis C virus NS3 protease and NS4A cofactor peptide as a single-chain protein.
    Dimasi N; Pasquo A; Martin F; Di Marco S; Steinkühler C; Cortese R; Sollazzo M
    Protein Eng; 1998 Dec; 11(12):1257-65. PubMed ID: 9930676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the sequence on NS4A required for enhanced cleavage of the NS5A/5B site by hepatitis C virus NS3 protease.
    Shimizu Y; Yamaji K; Masuho Y; Yokota T; Inoue H; Sudo K; Satoh S; Shimotohno K
    J Virol; 1996 Jan; 70(1):127-32. PubMed ID: 8523516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of hepatitis C virus NS3 protease and helicase activities through the interaction with NS4A.
    Gallinari P; Paolini C; Brennan D; Nardi C; Steinkühler C; De Francesco R
    Biochemistry; 1999 Apr; 38(17):5620-32. PubMed ID: 10220351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus NS3/4A protease.
    Kwong AD; Kim JL; Rao G; Lipovsek D; Raybuck SA
    Antiviral Res; 1998 Dec; 40(1-2):1-18. PubMed ID: 9864043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Product inhibition of the hepatitis C virus NS3 protease.
    Steinkühler C; Biasiol G; Brunetti M; Urbani A; Koch U; Cortese R; Pessi A; De Francesco R
    Biochemistry; 1998 Jun; 37(25):8899-905. PubMed ID: 9636031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complex of NS3 protease and NS4A peptide of BK strain hepatitis C virus: a 2.2 A resolution structure in a hexagonal crystal form.
    Yan Y; Li Y; Munshi S; Sardana V; Cole JL; Sardana M; Steinkuehler C; Tomei L; De Francesco R; Kuo LC; Chen Z
    Protein Sci; 1998 Apr; 7(4):837-47. PubMed ID: 9568891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrochemical detection of hepatitis C viral NS3-4A protease.
    Sowole MA; Kraatz HB
    Analyst; 2012 Mar; 137(5):1120-4. PubMed ID: 22288070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of mimotopes mimicking an immunodominant conformational epitope on the hepatitis C virus NS3 helicase.
    Jolivet-Reynaud C; Adida A; Michel S; Deléage G; Paranhos-Baccala G; Gonin V; Battail-Poirot N; Lacoux X; Rolland D
    J Med Virol; 2004 Mar; 72(3):385-95. PubMed ID: 14748062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of the immune response to a major, conformational B-cell epitope on the hepatitis C virus NS3 region defined by a human monoclonal antibody.
    Mondelli MU; Cerino A; Boender P; Oudshoorn P; Middeldorp J; Fipaldini C; La Monica N; Habets W
    J Virol; 1994 Aug; 68(8):4829-36. PubMed ID: 7518528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular determinants of TRIF proteolysis mediated by the hepatitis C virus NS3/4A protease.
    Ferreon JC; Ferreon AC; Li K; Lemon SM
    J Biol Chem; 2005 May; 280(21):20483-92. PubMed ID: 15767257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.